๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Particle beam radiotherapy for head and neck tumors: Radiobiological basis and clinical experience

โœ Scribed by Barbara Alicja Jereczek-Fossa; Marco Krengli; Roberto Orecchia


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
153 KB
Volume
28
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Background.

Head and neck tumors are often located near critical organs, making it impossible to deliver a dose of conventional radiotherapy high enough to eradicate the disease. Our aim was to review the potential benefits and available clinical experience of particle beam therapy (hadrontherapy) in the treatment of these tumors.

Methods.

A review of the literature was carried out through a MEDLINE search (publications between 1980 and 2005).

Results.

A review of the available clinical data shows that particle beam therapy can offer several radiobiological and physical advantages over conventional photon radiotherapy: improved dose distribution permits dose escalation within the target and optimal sparing of normal tissue. Preclinical and clinical studies suggest that there may be benefits to using hadrontherapy for tumors characterized by poor radiosensitivity and critical location. At present, the most used hadrons are protons and, as yet on an experimental basis, carbon ions. It is now well accepted that there are certain indications for using proton therapy for skull base tumors (chordoma and chondrosarcoma), paranasal sinus carcinomas, selected nasopharyngeal tumors, and neutron/ion therapy for salivary gland carcinomas (in particular, adenoid cystic tumors). Its viability in other cases, such as locally advanced squamous cell carcinoma, melanoma, soft tissue sarcoma, and bone sarcoma, is still under investigation.

Conclusions.

Hadrontherapy can be beneficial in the treatment of tumors characterized by poor radiosensitivity and critical location. Further clinical and radiobiological studies are warranted for improved selection of patient population. ยฉ 2006 Wiley Periodicals, Inc. Head Neck, 2006


๐Ÿ“œ SIMILAR VOLUMES


Initial clinical experience with helical
โœ Allen M. Chen; Richard L. S. Jennelle; Radhika Sreeraman; Claus C. Yang; Tianxia ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 153 KB

## Abstract ## __Background.__ To report a singleโ€institutional experience with the use of helical tomotherapy (HT)โ€based intensityโ€modulated radiotherapy (IMRT) for head and neck cancer. ## __Methods.__ Seventyโ€seven consecutive patients were treated with HT for squamous cell carcinoma of the h

Early experience with a hybrid accelerat
โœ Sandra Nuyts; Piet Dirix; Robert Hermans; Vincent Vander Poorten; Pierre Delaere ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 326 KB ๐Ÿ‘ 1 views

## Abstract ## Background. Our aim was to determine feasibility and efficacy of a hybrid radiotherapy schedule in locally advanced head and neck cancer. ## Methods. Seventyโ€three patients with locally advanced head and neck cancer were irradiated according to a hybrid accelerated schedule consis

Therapeutic effect of recombinant human
โœ Hong Gyun Wu; Si Yeol Song; Yeon Sil Kim; Young Taek Oh; Chang Geol Lee; Ki Chan ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 356 KB ๐Ÿ‘ 2 views